Cargando…
237P Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732918/ http://dx.doi.org/10.1016/j.iotech.2022.100226 |
_version_ | 1784846238015815680 |
---|---|
author | Cortellini, A. Dettorre, G. Dafni, U. Aguilar Company, J. Castelo-Branco, L. Lambertini, M. Gennatas, S. Rogado, J. Vinal Lozano, D. Harrington, K.J. Tsourti, Z. Michielin, O.A. Pommeret, F. Brunet Vidal, J.M. Tabernero, J. Pentheroudakis, G. Gennari, A. Peters, S. Romano, E. Pinato, D.J. |
author_facet | Cortellini, A. Dettorre, G. Dafni, U. Aguilar Company, J. Castelo-Branco, L. Lambertini, M. Gennatas, S. Rogado, J. Vinal Lozano, D. Harrington, K.J. Tsourti, Z. Michielin, O.A. Pommeret, F. Brunet Vidal, J.M. Tabernero, J. Pentheroudakis, G. Gennari, A. Peters, S. Romano, E. Pinato, D.J. |
author_sort | Cortellini, A. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9732918 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97329182022-12-09 237P Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries Cortellini, A. Dettorre, G. Dafni, U. Aguilar Company, J. Castelo-Branco, L. Lambertini, M. Gennatas, S. Rogado, J. Vinal Lozano, D. Harrington, K.J. Tsourti, Z. Michielin, O.A. Pommeret, F. Brunet Vidal, J.M. Tabernero, J. Pentheroudakis, G. Gennari, A. Peters, S. Romano, E. Pinato, D.J. Immunooncol Technol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2022-12 2022-12-09 /pmc/articles/PMC9732918/ http://dx.doi.org/10.1016/j.iotech.2022.100226 Text en Copyright © 2022 European Society for Medical Oncology. Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Cortellini, A. Dettorre, G. Dafni, U. Aguilar Company, J. Castelo-Branco, L. Lambertini, M. Gennatas, S. Rogado, J. Vinal Lozano, D. Harrington, K.J. Tsourti, Z. Michielin, O.A. Pommeret, F. Brunet Vidal, J.M. Tabernero, J. Pentheroudakis, G. Gennari, A. Peters, S. Romano, E. Pinato, D.J. 237P Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries |
title | 237P Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries |
title_full | 237P Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries |
title_fullStr | 237P Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries |
title_full_unstemmed | 237P Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries |
title_short | 237P Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries |
title_sort | 237p immune checkpoint inhibitor therapy and outcomes from sars-cov-2 infection in patients with cancer: a joint analysis of oncovid and esmo-cocare registries |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732918/ http://dx.doi.org/10.1016/j.iotech.2022.100226 |
work_keys_str_mv | AT cortellinia 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries AT dettorreg 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries AT dafniu 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries AT aguilarcompanyj 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries AT castelobrancol 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries AT lambertinim 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries AT gennatass 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries AT rogadoj 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries AT vinallozanod 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries AT harringtonkj 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries AT tsourtiz 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries AT michielinoa 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries AT pommeretf 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries AT brunetvidaljm 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries AT taberneroj 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries AT pentheroudakisg 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries AT gennaria 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries AT peterss 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries AT romanoe 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries AT pinatodj 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries |